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Traditional Japanese medicine uses the leaves of Kumaizasa bamboo extracted in hot water at
100 C. For this study, we developed a new, ‘vigorous’ extraction method involving steps at 100,
121 and 196 C. This procedure not only yielded greater amounts of extract but also with
significant increase in immunostimulating activity, which induces activation of human natural
killer (NK) cells, macrophages and potent induction of IL-2, IL-12 and IFN-g in tumor bearing
mice. The efficacy of the extract to facilitate phagocytosis and nitric oxide production by mouse
peritoneal macrophages was determined and compared with that of 1,3-b-glucan. Anti-tumor
activity was evaluated in vivo in several mouse tumor models (S-180, C38 and Meth-A). Oral
administration of the extracts was carried out when tumor reached size of approximately 6mm
at concentrations of 0.05% or higher. The extracts significantly suppressed tumor growth in
S-180 and C38 tumor models. Overall survival was significantly prolonged in the treatment
group than that of control. Activation of macrophages and NK cells by the extracts suggests
that the anti-tumor efficacy of the extract is mediated by immunopotentiation. The extracts
resolved into three major fractions (F-I, F-II and F-III) in Sephadex gel chromatography.
Fraction F-I consists of 1,3-b-glucan and stimulated both macrophages and NK cells suggesting
that it may be the primary immunopotentiating factor in suppressing cancer. Fraction F-III has
potent free radical scavenging effects and may play an important role in cancer prevention.
These results warrant further translation and clinical investigations.
Keywords: high-temperature/high-pressure extraction – multistep extraction – NK cell
activation – macrophage activation – 1,3-b-glucan
Introduction
One of the causal factors of tumor progression is
suppression of immune functions. Restoring the immune
competence can be one of the primary strategies of active
immunotherapy. Polysaccharides from mushrooms or
microbial cell-wall components were shown to be efficient
immunostimulating agents. The extracts of the Kumaizasa
bamboo leaves were shown to be anti-inflammatory (1).
We hypothesized that the extracts may also posses
immunopotentiating function. To test the hypothesis, we
have undertaken this investigation. The first objective was
to evaluate the anti-tumor activity and the immunopoten-
tiating efficacy of the bamboo extracts under vigorous
conditions. The second objective is to identify the active
principle in the extracts that is associated with immuno-
potentiation. The results of this investigation encourage
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properly cited.undertaking further translational and clinical investigation
with the bamboo leaf extracts for treatment of cancer.
Methods
Materials
Interleukin (IL)-2, IL-12 and interferon-g (IFN-g) were
purchased from Pierce Biotechnology (Rockford, IL).
1,3-b-Glucan from Lentinula edodes (MW 10000–40000),
1,3-b-glucanase from Arthrobactor sp. and rabbit anti-
asialo GM1 were obtained from Wako Pure Chemical
Industries (Osaka, Japan). RPMI-1640 and fetal bovine
serum (FBS) for culture medium was purchased from
Invitrogen (Carlsbad, CA). All other reagents were
obtained from commercial sources and were used without
further purification.
High-Pressure, High-Temperature Extract of Kumaizasa
Bamboo Leaves
Kumaizasa is a bush type of bamboo, with a wider leaf
than that of the common bamboo found in southern
Japan that grows predominantly in the Hokkaido region.
The material used here, provided by the Cosmo Bios
Research Institute (Akahira, Hokkaido, Japan), was
extracted under extremely high temperature and high
pressure (via two steps). First, it was extracted at 100 C
for 60min, and residues were subjected to extraction at
121 C, 2atm, for 30min. Second, the residues were
further treated at 196 C, 15atm, for 5min, and then
extracted at 120 C for 30min. The total sugar concen-
tration was determined by the phenol–sulfuric acid
method with glucose as the standard (2). To identify
the active principle in the extracts, they were subjected
to a Sephadex G-50 Fine gel chromatography column
(height 90cm diameter 1.2cm; GE Healthcare, Uppsala,
Sweden), with the elution buffer being 0.01M phosphate-
buffered 0.15M NaCl (PBS). Fractions were collected
by monitoring absorbance at 280 and 370nm. The
1,3-b-glucan contents of these extracts, of three major
fractions of different molecular size (F-I, F-II, F-III)
from the extracts and of a conventionally prepared
extract were determined by using a 1,3-b-glucan assay
kit consisting of limulus lysate (Maruha, Tokyo, Japan),
according to the manufacturer’s instructions (3). Further
amount of total phenolics in the bamboo leaf extracts
and major fractions were also determined according to
Folin–Ciocalteu method (4). Total phenolics content was
expressed as caffeic-acid equivalents.
To further characterize F-I, 10mg of F-I in 1ml
of PBS, pH 7.5, was added to 200units ml
 1 of
1,3-b-glucanase, which was obtained from Arthrobactor
sp., and was incubated at 25 C in a shaking water bath
for 2 days. During the incubation, aliquots of the
reaction mixture were taken at given time intervals, of
which the enzyme reaction was stopped by heating at
100 C, and then amount of free glucose generated was
quantified by using a high-performance liquid chroma-
tography (HPLC) system (LC-VP column; Shim-pack
ISA-07/S2504; Shimadzu, Kyoto, Japan) with post-
column fluorescence derivatization, which reacted with
arginine.
Animals
Male ddY (8 weeks of age), C57BL/6Cr Slc mice
(6 weeks of age) and female BALB/c mice were pur-
chased from SLC, Inc. (Shizuoka, Japan). Mice were
housed in groups of four or five per cage and were
maintained at 22 1 C and 55 5% relative humidity.
Lighting was automatic on a 12-h light/dark cycle. All
experiments were carried out according to the Laboratory
Protocol of Animal Handling, Kumamoto University.
Cell Lines
K562 cells (human chronic myeloid leukemia) and YAC-
1 cells (murine lymphoma) were obtained from Riken
Bioresource Center Cell Bank (Tsukuba, Japan) and were
maintained in RPMI-1640 containing 10% FBS, 100units
ml
 1 penicillin and 100mgml
 1 streptomycin.
Diet
The experimental diet was prepared by Funabashi Farm
(F2; Funabashi, Chiba, Japan). Bamboo leaf extracts
mixed with the diet at 0.05–0.5% (w/w) were vacuum
packed followed by gamma ray sterilization and stored at
4 C until use.
Effect of Bamboo Leaf Extracts and IL-2 on In Vitro
Cytotoxicity of Human Natural Killer Cells against
K562 Cells
The Conray–Ficoll method was used to isolate human
peripheral blood mononuclear cells from venous blood
obtained from healthy volunteers (5). Human natural
killer (NK) cells from heparinized peripheral blood from
healthy volunteers were collected by using a StemSep kit
(StemCell Technologies, Vancouver, Canada). Bamboo
leaf extracts were dissolved in PBS. NK cells (2 10
6cells)
were pre-treated with either IL-2 for comparison or the
extracts at final concentrations of 1–100mgml
 1,o r
different fractions of the F-I, F-II, F-III and 1,3-b-
glucanase-digested F Ia t3 7  C for 48h in 5% CO2/air.
NK cells incubated with PBS were used as the control.
After incubation, NK cells were washed with culture
medium and then used for examination of cytotoxic
activity against 2 10
4 target K562 cells in the same
culture medium at various ratios [effector/target (E/T)
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microtiter plates (Becton Dickinson, Franklin Lakes, NJ).
The microtiter plates were centrifuged at 200g for 5min
to facilitate contact between effector with target cells
followed by incubation at 37 C for 4h in 5% CO2/air.
After incubation, the viable cell number was assayed with
a CellTiter-Glo Luminescent Cell Viability Assay kit
(Promega, Madison, WI). NK cytotoxic activity was
calculated by using the following formula: % lysis=
(1   viable cells in tested group/viable cells in no-drug
control group) 100, where the positive no-drug control
group consisted of K562 cells treated with NK cells
activated by IL-2at 0.1–1.0mgml
 1 in the same culture
medium as the reference.
In Vitro Phagocytic Activity and Nitric Oxide
Production by Mouse Macrophages
Peritoneal macrophages were obtained by intraperitoneal
injection of 10% proteose peptone (Becton Dickinson)
elicited in BALB/c mice. Peritoneal macrophages
(1 10
5cells/well) were incubated in plastic plates
(f30mm), with a cover glass placed in the bottom, at
37 C for 1h in 5% CO2/air. Macrophages were then
treated for 24h with the extracts at concentrations of
0.1–100mgml
 1, or with different fractions (F-I, F-II,
F-III or 1,3-b-glucanase-digested F-I) at concentrations
of 10–1000mgml
 1. Then, 3ml of 1.0% suspension of
yeast (Saccharomyces cerevisiae) was added, and incuba-
tion continued for 30min under the same conditions.
The number of yeast cells phagocytosed were counted
in evaluating more than 200 macrophages under a
microscope.
Macrophages were similarly obtained from C57BL/6
mice, and 1 10
5cells/well) were then incubated in
RPMI-1640 medium with 10% FBS at 37 C for 20h
with 1,3-b-glucan from L. edodes at 1000mgml
 1 as a
reference, with bamboo leaf extract at 1000mgml
 1 or
with and different fractions (F-I, F-II, F-III) from the
extracts at 1000mgml
 1. After the incubation, the
production of nitric oxide (NO) was determined by use
of the Griess reagent.
Activation of Mouse Macrophages by Lipopolysaccharide
or Lipopolysaccharide Plus IFN-c
Peritoneal macrophages were obtained by intraperitoneal
injection of 10% proteose peptone. These macrophages
(1 10
5cells/well) were incubated with 1.0mgml
 1 lipo-
polysaccharide (LPS) or 1.0mgml
 1 LPS plus 0.2mgml
 1
IFN-g at 37 C for 20h in RPMI-1640 medium with 10%
FBS. Then, production of IL-12 was determined by
means of an enzyme-linked immunosorbent assay
(ELISA) using mouse ELISA kits (Pierce Biotechnology).
In Vivo Anti-tumor Activity of the Bamboo Leaf Extract
Against S-180, C38 and Meth-A Solid Tumor Models
S-180 tumors were maintained in ascitic form in ddY
mice. S-180 cells (2 10
6) obtained from ascitic tumor
were implanted subcutaneously (s.c.) in the dorsal skin of
ddY mice. Mice bearing tumors 5–6mm in diameter were
selected for study of anti-tumor activity, 7–10 days after
tumor cell injection. For each experiment, control mice
were fed a chemically defined basal diet without bamboo
leaf extract. Experimental groups were fed a diet
supplemented with 0.05–0.5% of the extract. During the
experiments, tumor volume, body weight, food intake
and survival rate of mice were measured daily. Tumor
volume (V) was calculated by use of the following
formula: V=(L W
2)/2, where L is the longitudinal
cross-section and W is the transverse section of the solid
tumor. Eight mice were used for each group. Similar
experiments were carried out with the C38 solid tumor
model, in which tumor fragments of about 30mg were
implanted s.c. in the dorsal skin of C57BL/6 mice by
using a trocker needle.
In addition, anti-tumor activity of bamboo leaf extract
was examined in the Meth-A solid tumor model. As with
S-180 tumors and Meth-A cells were maintained by
intraperitoneal passage in BALB/c mice. Meth-A cells
(1 10
6) were implanted s.c. in the dorsal skin of BALB/c
mice, and 7 days later when the tumor diameter was
 5mm, the anti-tumor experiment was conducted via the
same protocol as that described above.
Effect of Bamboo Leaf Extracts on Cytokine Induction
and NK Cell Activation in C38 Tumor-bearing Mice
As in the aforementioned protocol, C38 tumors were
implanted in C57BL/6 mice, and when tumors became
palpable (f approx 4mm), mice were fed a diet contain-
ing bamboo leaf extract. At 21 days after treatment, all
mice were killed under ether anesthesia, and blood, spleen
and tumor samples were obtained, for quantification of
serum IL-2, IL-12 and IFN-g by using mouse ELISA kits
(Pierce Biotechnology). Splenic NK cells were prepared
by using a StemSep kit, and cytotoxicity of NK cells
against target YAC-1 cells cultured in vitro in RPMI-
1640 medium with 10% FBS was examined. Each tumor
sample was also weighed.
To investigate the role of NK cells in anti-tumor
activity induced by the extracts, a similar set of in vivo
experiments was carried out by eliminating NK cell
function with anti-asialo GM1 antibody in C38 solid
tumor. When C38 tumors were  4mm in diameter, one
group of mice was fed a diet containing bamboo leaf
extract at 0.1%, and then mice were injected intrave-
nously with diluted (4 times) anti-asialo GM1 antibody
on days 12, 15 and 19 (6). Another group fed with the
same diet did not receive the antibody treatment.
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All data were expressed as means SD. Student’s t-test
was used to determine the significance of differences
between each experimental group.
Results
Comparison of Efficiency of Vigorous High-temperature,
High-pressure Extraction and Hot-water Extraction
To compare the efficiency of our high-temperature, high-
pressure multi-step extraction method and the conven-
tional hot-water (boiling water) extraction method, for
each soluble extract we quantified the amount of total
sugar (glucose equivalent), optical absorption and phe-
nolic compound at every step. Figure 1 shows that the
total sugar content of extracts obtained via the vigorous
extraction method was about five times higher than that
obtained via hot-water extraction. Moreover, UV absorp-
tion of the extracts was also about six times higher both
at 280 and 370nm compared to that of hot-water
extraction (Table 1). Further, total phenolics content
from the vigorous extraction was two times higher than
that from hot-water extraction (Table 1).
To identify the active principle(s) in the extracts, we
used Sephadex G-50 gel chromatography for purification.
The extracts contained three major fractions: F-I
(45kDa but 520kDa); F-II (1–2kDa) and F-III
(51kDa) (Fig. 2A). F-I contained 1,3-b-glucan, as
revealed by the modified limulus test, which is specific
for 1,3-b-glucan (Table 1). About 65% (w/w) free glucose
was recovered from F-I by 1,3-b-glucanase digestion
(Fig. 2C), which indicates that the majority of F-I was
1,3-b-glucan; the remaining portion requires further
chemical classification. In comparison, the elution profile
of preparation by the conventional extraction method
was completely different from that of vigorous extraction
(Fig. 2A versus 2B).
Effect of Bamboo Leaf Extracts on In Vitro Cytotoxic
Activity of Human NK Cells
To examine biological activities of unfractionated
bamboo leaf extracts, we first evaluated their cytotoxic
activity of NK cells in vitro. Cytotoxic NK activity
against K562 cells increased in parallel with the increase
in the E/T ratio (Fig. 3), with the 100mgml
 1 extract at
the E/T of 50 showing the highest cytotoxicity. More
important, the extracts showed that its immunopotentiat-
ing effect on NK cell cytotoxicity was comparable to that
of pure IL-2 (Fig. 3A versus 3B). This NK cell activation
of F-I was suppressed about 50% by 1,3-b-glucanase
digestion, which indicates a role for 1,3-b-glucan
(Fig. 3C).
The Effect of Bamboo Leaf Extracts on Phagocytic
Activity and Production of NO by Mouse Macrophages
The extracts significantly increased macrophage phagocy-
tic activity compared with the untreated group (Fig. 4A),
with phagocytic activity induced by the extracts being
Table 1. Incresed extract ability: comparisons between conventional versus vigorous extraction, and each values of the Sephadex G50
Sample Amount of
1,3-b-glucan
(mgm g
 1)
a
Amount of
total phenolics
(mgm g
 1)
b
Value of absorbance, relative
(fold increase)
280nm 370nm
Extract from conventional hot-water extraction 0.2 35.1 35.6 (1) 7.1 (1)
Extract from vigorous extraction (unpurified) 316.5 65.2 202.0 ( 5.7) 43.5 ( 6.1)
Sephadex G-50 fractions
F-I 317.3 6.3 0.3 0.1
F-II 0.02 41.8 1.1 0.6
F-III 0.001 17.1 0.9 0.4
aDetermined by using the modified Limulus test, which is specific for b–glucan (3). See total sugar content by phenol–sulfuric a acid method in
Figure 1;
bDetermined using Folin–Ciocalteu method (4).
Figure 1. Comparison of the efficiency under conventional hot-water
extraction (A) and under multi-step vigorous high-temperature, high-
pressure extraction (B). Extraction of each step is shown in B.
450 Anti-tumor activity of bamboo leaf extractsabout two to three times higher at 1.0, 10 and 100mgml
 1
than that of the control. Figure 4B illustrates phago-
cytic activity of macrophage induced by each fraction:
F-I (1,3-b-glucan) significantly increased. This result was
similarly seen in the unfractionated extract. However, this
potentiation of phagocytotic activity of F-II was not
so apparent, and also the 1,3-b-glucanase-digested F-I
fraction had almost no activity (F-I versus digested F-I at
100 or 1000mgml
 1). F-III seemed to have 510% of the
activity of F-I. Figure 4C shows that bamboo leaf extract
and F-I significantly increased macrophage NO produc-
tion, similar to 1,3-b-glucan from L. edodes. F-I induced
higher NO production than the original unfractionated
extract, whereas F-II and F-III caused almost no increased
NO production.
Effect of Mouse Strain, C57BL/6 versus BALB/c, on
Activation of Macrophages by LPS or LPS Plus IFN-c
As shown in Fig. 5, macrophages from both mouse
strains stimulated by LPS or LPS plus IFN-g showed
significantly increased IL-12 and NO induction compared
with untreated groups. A notable finding was that
C57BL/6 macrophages produced 10 times higher
amounts of IL-12 and NO than BALB/c macrophages.
Anti-tumor Activity of Bamboo Leaf Extracts in Mice
S-180 Solid Tumor in the ddY Mouse Model
All doses of bamboo leaf extracts significantly suppressed
tumor growth compared with the control, with the
extracts at the 0.1% concentration showing the strongest
activity (Fig. 6A). This treatment also greatly improved
the survival rate of tumor-bearing mice, again with the
extracts at 0.1% producing the highest survival: i.e.
the %T/C (treated/control) was 142.6% (Fig. 6B).
Furthermore, a significant number of tumors in mice
fed with bamboo leaf extracts regressed completely; the
numbers of tumor-free mice after treatment/initial num-
bers of tumor-bearing mice were 1/8, 3/8 and 2/8 at
extract concentrations of 0.05, 0.1 and 0.5%, respectively.
Treated groups showed no significant difference in body
weight (data not shown).
To compare anti-tumor activity of the conventional
boiling water (100 C) extraction and the vigorous
extraction methods, a similar set of in vivo experiments
was performed in S-180 solid tumor model with the
extracts at the 0.1% concentration. Tumor growth was
not suppressed in the conventional extraction group
(Fig. 6C).
Figure 2. (A) Sephadex G-50 gel chromatography of bamboo leaf extracts under vigorous condition and conventional condition (B). Absorbance
at 280nm (open square); absorbance at 370nm (open diamond). Values of glucose equivalent obtained by the phenol–sulfuric acid method
(closed square). Each tube contained 6.0ml. (C) Time course of liberation of free glucose during digestion of 10mg ml
 1F-I with 200units of
1,3-b-glucanase (see text for details).
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As Fig. 7A shows, bamboo leaf extract significantly
suppressed tumor growth compared with the control.
This treatment also greatly improved the mean survival
rate (%T/C was 158%) (Fig. 7B).
Change in Immunological Parameters in C38
Tumor-bearing Mice
Bamboo leaf extract at 0.1% also significantly suppressed
C38 tumor growth at 21 days after treatment compared
with the control (Fig. 8). The average tumor weight of
the treated group was 1.54 0.46g, whereas that of the
untreated control group was 2.65 0.51g, significantly
higher.
To further clarify the anti-tumor effect of the bamboo
leaf extracts, we measured IL-2, IL-12 and IFN-g levels
in mice after feeding the extract in the diet for 21 days.
Serum levels IL-12 and IFN-g were significantly raised
in C38 tumor-bearing mice fed with extracts at the 0.1%
concentration compared with levels in the control group
(Table 2). More important, a significantly higher
(P50.01) concentration of IL-12 was induced by the
extracts, which may stimulate NK cell activity, and, in
fact, significantly elevated cytotoxic activity of splenic
NK cells occurred in C38 tumor-bearing mice (Fig. 8B).
To clarify anti-tumor activity mediated by the NK cells,
we used anti-asialo GM1 antibody in the C38 tumor
model. Mice fed the bamboo leaf extract at 0.1% had
significantly suppressed tumor growth, whereas a similar
group of mice that received the extracts and anti-asialo
GM1 antibody treatment showed no significant suppres-
sion of tumor growth, with tumor volume being similar
to that of the control (Fig. 9).
Meth-A Solid Tumor in the BALB/c Mouse Model
The bamboo leaf extract had no significant effect on
Meth-A tumor growth and survival rate of mice
compared with the control (data not shown). This finding
is consistent with the fact that this strain had a much
lower response than that of the C57BL/6 strain (about
10%) to LPS or LPS plus IFN-g treatment, as shown in
Fig. 5.
Discussion
Alternative therapeutic tools obtained from plants to
fight cancer have garnered great interest. In the present
study, we demonstrated the remarkable anti-tumor
activity of bamboo leaf extracts obtained under vigorous
high-temperature, high-pressure extraction conditions.
To our surprise, these extracts had far superior activity
than extracts obtained via the conventional hot water
method, as seen in Table 1, Fig. 1 and Fig. 6C. This new
aqueous extraction method not only yielded a higher
Figure 3. Enhancement of cytotoxic activity of human NK cells at
various concentrations of bamboo leaf extract at different E/T ratios
(n=8/group). Suspensions of effector NK cells were added to target
K562 cells at E/T ratios of 5:1, 25:1 or 50:1. (A) Cytotoxic activity for
control, PBS (closed circle); IL-2at 1mgml
 1 (open square); IL-2at
10mgml
 1 (closed square). (B) That for bamboo leaf extracts at
1mgml
 1 (closed triangle), 10mgml
 1 (open diamond) and 100mgml
 1
(closed diamond). (C) That for unfractionated bamboo leaf extract at
100mgml
 1 (closed diamond), F-I at 100mgml
 1 (closed triangle), F-II
at 100mgml
 1 (closed square), F-III at 100mgml
 1 (open square), 1,3-b-
glucanase-digested F-I at 100mgml
 1 (open triangle) and PBS (closed
circle). Values represent means SD. **P50.01 and *P50.05 versus
controls.
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increased the immunopotentiation effect of the extracts
(Fig. 6C). Preliminary extract purification with Sephadex
G-50 and G-100 chromatography produced three major
fractions of different molecular size: F-I was large,
between 5 and 20kDa; F-II was of medium size,
1–2kDa; and F-III was small, 51kDa (Fig. 2A). F-II
and F-III were not obtained by the conventional hot
water extract (Table 1). F-I contained predominantly
1,3-b-glucan because 1,3-b-glucanase digested the major-
ity of F-I free glucose (Fig. 2C).
With regard to biological activity, F-I significantly
augmented the phagocytic activity of macrophages
(Fig. 4B) to a degree similar to that achieved by
unfractionated bamboo leaf extract (Fig. 4A). F-I
digestion by 1,3-b-glucanase eliminated the enhancing
potency of the phagocytic activity of F-I (Fig. 4B). F-II
showed almost no activity and F-III, only very weak
activity. Furthermore, F-I, similar to unfractionated
bamboo leaf extract, significantly increased macrophage
NO production (Fig. 4C). This F-I-stimulated NO
production was comparable in potency to that of
1,3-b-glucan from L. edodes, an immunopotentiating
agent approved for use in Japan. F-II and F-III did
not increase NO production compared with controls.
As shown in Table 1 and other data in Results section,
the present preparation (vigorous extraction) and con-
ventional hot-water extraction product were greatly
different in the quality and quantity, namely the chro-
matographic pattern upon Sephadex G-50 column, UV
absorbing components as well as phenolic contents
(Figs. 1A, B and 2A, B). The difference in biological
activity was immense: practically no anti-tumor activity
in the conventional extracts was seen, while the present
extracts were clearly effective even at 0.05%, and more so
at 0.1% in the diet (Fig. 6C). This again shows
qualitative difference between the two extractions.
Cytotoxic activity of human NK cells obtained from
peripheral venous blood of healthy volunteers was
increased by bamboo leaf extracts at E/T ratios of 5,
25 and 50 (Fig. 3). Among the three major fractions, F-I
induced the greatest increase in cytotoxic activity of these
NK cells (Fig. 3C). Digestion of F-I by 1,3-b-glucanase
resulted in little cytotoxic activity (Fig. 3C). Significant
NK cell activation by the extract was also observed in
tumor-bearing C57BL/6 mice (Fig. 8B). Depletion of NK
Figure 4. In vitro phagocytic activity of peritoneal macrophages from the ddY mouse (A and B), and NO production by C57BL/6 mouse
macrophages (C). ddY mouse macrophages were treated with different doses of bamboo leaf extracts; control macrophages did not receive the
extracts (A). (B) Macrophages were treated with different doses of unfractionated bamboo leaf extracts or different fractions (F-I, F-II, F-III and
1,3-b-glucanase-digested F-I) of extract, or PBS (control). (C) Macrophage NO production after treatment with PBS (control), 1,3-b-glucan from
L. edodes (reference), unfractionated bamboo leaf extract, F-I, F-II or F-III at 100mgml
 1. Values represent means SD (n=3). **P50.01 and
*P50.05 (extracts versus control).
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model eliminated this anti-tumor activity (Fig. 9). Thus,
NK cells appeared to serve as a major effector of tumor
growth suppression (Figs 6A, 7A and 9).
Marked anti-tumor activity as evidenced by an
improved survival was found for extracts in S-180 and
C38 tumor-bearing mice (Figs 6B and 7B). However,
improved survival was not the case for Meth-A tumor-
bearing BALB/c mice. It is interesting to note that
BALB/c mice are known to have a low response to LPS
and IL-12. C57BL/6 macrophages produced 10 times
more IL-12 and NO than did BALB/c macrophages
(Fig. 5). This finding may indicate that a low immune
response to bamboo leaf extract in BALB/c mice may
result in the poor -tumor response against Meth-A tumor
in this mouse strain.
We demonstrated that serum levels IL-12 and IFN-g
and splenic NK cell activity were significantly raised in
C38 tumor-bearing mice fed with extract at the 0.1%
concentration compared with levels in the control group
(Table 2, Fig. 8). These results suggest that the extracts
magnified the immune response even in the host bearing
tumor, thereby suppressing tumor growth.
In any case, the potency of these anti-tumor activities is
comparable or similar to, published results with an
advanced formulation technology (liposome formulation)
of conventional anti-cancer agents, such as cisplatin
(CDDP) or Adriamycin (ADM) in the same mouse
models (7). The tumor inhibition rates for these ADM
and CDDP were 55.3 and 72.6% in S-180 solid tumor
model (8,9). In our study, bamboo leaf extracts at the
concentration of 0.1% showed 70.1%, which is compa-
rable to that of ADM and CDDP. Thus, these results
indicate that the high-temperature and high-pressure
extracts of bamboo leaves can offer a potential and
alternative for anti-tumor strategy without any obvious
toxicity.
We reported earlier that a hot-water extract of
shitake mushroom, KS-2, which contained water-soluble
mannan and glucans, could be absorbed after oral
administration, enter the blood circulation and accumu-
late in the kidney, liver and lymph nodes via intestinal
uptake (10–12). Furthermore, some polysaccharide frag-
ments were recovered from urine. This intestinal uptake
and entry into circulation may also be valid for these
bamboo leaf extracts, because of a similar chemical
entity, b-glucan (12).
Several polysaccharide preparations such as lentinan,
schizophyllan, krestin and KS-2 contain b-glucans (or
1,3-b-glucans) and that from various species of other
mushrooms (Agaricus blazei) (10–19). Among these
preparations, lentinan and krestin were approved by
Japanese Government and are used as biological response
modifiers for anti-cancer. Their immunostimulating effect
Figure 5. Difference in LPS response among different mouse strain—C57BL/6 (A) and BALB/c (B)—as related to macrophage response (IL-12 and
NO induction) to activation by LPS or LPS plus IFN-g. Macrophages were obtained as described in Methods. Note the great difference in the scale
of the ordinates. Values are means SD. *P50.05 and **P50.01 versus the normal group.
454 Anti-tumor activity of bamboo leaf extractsFigure 6. Anti-tumor activity of bamboo leaf extracts. Tumor growth (A), and survival curves (B), for S-180-bearing ddY mice fed with the whole
extract. (C) A comparison of anti-tumor activity between vigorous extraction and conventional hot-water extraction in S-180-bearing ddY mice. ddY
mice were inoculated with 2 10
6S-180 cells. (A) Anti-tumor activity of the control die and of the diets containing bamboo leaf extracts added at
0.05% (open square), 0.1% (closed triangle) or 0.5% (open diamond). Values are means SD. *P50.05 and **P50.01 versus controls. The arrow
indicates the starting point of feeding the diet containing the extracts. (B) Survival curves for the control diet and the diets containing bamboo leaf
extracts at 0.05, 0.1 or 0.5%. Numbers of tumor free mice after treatment were (tumor free/tumor). (C) Anti-tumor activity of the control diet (closed
circle) and of diets containing bamboo leaf extract (at 0.1%) produced via the conventional hot-water method (open triangle) or the vigorous
extraction method (closed triangle). **P50.01 versus the control. (D) Dose response on tumor size on day 32 (left) and survival on day 100 (right).
Figure 7. Anti-tumor activity of bamboo leaf extract (A) and survival curves (B) in the C38 solid tumor model. Mouse colon C38 tissue specimens
(about 30mg) were implanted s.c. in C57BL/6 mice. (A) Anti-tumor activity of the control diet (closed circle) and of the diet containing bamboo leaf
vigorous extract at 0.1% (closed triangle). *P50.05 versus the control. (B) Survival curves for the control diet and the diet containing bamboo leaf
extract added at 0.1%.
eCAM 2010;7(4) 455results in activation of not only NK cells but also
macrophages, which are known to produce IL-12 and
induce production of IFNs, and thus anti-tumor effects
as well (18). We (KS-2) and others (A. blazei and other
mushrooms) discussed that these anti-tumor activity
was mediated by multiple elements such as induction of
IFN-g, IL-2 and IL-12 and activation of macrophages
and NK cells (10–18).
A dietary supplementation of vegetable soup prepara-
tion given in clinical trials with patients having stage III
and IV non-small cell lung cancer was reported (20,21).
The diets, which contain vegetables and fruits with
multiple functional components have no side-effects,
and believed to be effective for prevention of cancer
and inflammation. On the basis of data presented here,
we believe that an extract from leaves of Kumaizasa has
a beneficial role in cancer treatment, via stimulating the
immune response, and cancer prevention. Another
candidate macromolecular components in plants, lignin
is also known to have very potent radical-scavenging
activity (22,23), thus it may also warrant attention.
Treatment of tumors with conventional cytotoxic
agents can reduce the number of cells to not less than
10
7–10
10, but often simultaneously with suppression of
the host’s immune system. On the contrary, injection of
tumor cells of about 5 10
5 to 5 10
6 cells into
immunocompetent healthy mice in the experimental
tumor model usually results in rapid tumor growth
palpable within 2 weeks. Similarly, under clinical setting,
rapid mass can be formed after chemotherapy, because
formidably large numbers of surviving tumor cells still
remain unkilled and patients cannot tolerate any further
dosing of chemotherapy. To make the situation worse, a
patient’s immune system is often greatly suppressed by
such treatment that new solid tumor can recur with
Figure 8. Anti-tumor activity of bamboo leaf vigorous extracts. (A) Weight of C-38 solid tumors after feeding of bamboo leaf extract at 0.1% in the
diet for 21 days (n=8/group). (B) splenic NK cell cytotoxic activity in the C38 solid tumor-bearing mice. Values are means SD. *P50.05 versus
the control. Effector NK cell suspension was added to target Yac-1 cells at the ratio of 50:1. Values are means SD. *P50.05 versus the control.
Figure 9. Involvement of NK cells anti-tumor activity of bamboo leaf
extract in the C38 solid tumor model. Anti-tumor activity of the control
diet (closed circle), the diet containing the extract at 0.1% (closed
triangle), or the diet containing the extract at 0.1% plus treatment with
anti-asialo GM1 antibody (open triangle). The open inverse triangle
indicates injection of anti-asialo GM1 antibody. **P50.01 versus the
control. The arrow at day 12 indicates the start of dietary extract
feeding of the test group.
Table 2. Effect of bamboo leaf extracts on serum cytokine in C38
tumor-bearing C57BL/6 mice
Sample Cytokine content (pgml
 1)
IL-2 IL-12 IFN-g
Control (no extract) 25.7 2.3 1266.3 256.3 69.5 7.9
Bambool leaf extracts 35.8 2.1 2223.1 544.0* 119.8 24.8*
n=8/group.
*P50.05.
Bamboo leaf extracts: extracts were fed at a concentration of 0.1% in
the diet for 21 days. Blood was obtained for analaysis on day 21 after
tumor injection. IL, interleukin; IFN, interferon.
456 Anti-tumor activity of bamboo leaf extractsrelative ease. Therefore, we still need potent immuno-
stimulating agents that have no side effects like this
bamboo extracts. Furthermore, the suppressed immune
state is related to a higher incidence of cancer in the aged
population, so immunostimulation may be useful for
cancer prevention among aged and high-risk populations.
In conclusion, we report here that a dietary supplement
of bamboo leaf extracts at a concentration of 0.1%
suppressed solid tumor growth and prolonged the life
span in S-180 and C38 models. Such oral administration
of the extracts induced Th1-type cytokine production.
Also, the extracts stimulated cytotoxic activity of NK cells
and macrophages both in vitro and in vivo. These results
strongly suggest the great potential of this bamboo leaf
extract as an anti-cancer and cancer preventive agent.
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